Pharmaceutical and Biotech facilities are routinely asked to make difficult research and manufacturing facility decisions based on product lines that may or may not have regulatory agency approval. This can put the company in an extremely risky and potentially costly position. The Science and Research Design Group can help to minimize these risks through comprehensive programming, design, and phasing options that can minimize risk, optimize output, and reduce disturbances to your existing operations.

Pfizer Bulk Biological Manufacturing Facility, Lincoln, Nebraska




Project:
Pfizer Bulk Biological Manufacturing Facility, Lincoln, Nebraska


Project Type:
New Construction


Description:
The Science and Research Design Group designed the three-story facility to meet stringent European Community (EC) standards for producing viral and bacterin products for world-wide distribution. Central services, located between viral and bacterin production, provides support in media preparation, material storage, and glassware washing/sterilization, as well as shipping and receiving. Each area has its own entrance, and human interchange between the areas is prohibited to avoid cross contamination. A 20-foot high concrete wall separates the new commons building with its conference facilities, supervisory offices, employee lounge, cafeteria, and landscaped courtyard from the secure manufacturing facility.


GSF:
159,000


Completion:
1992


Project Cost:
$31,000,000


Services:
Architecture, Laboratory Planning, Structural Engineering, Interior Design, Landscape Architecture.